Showing posts with label Healthcare. Show all posts
Showing posts with label Healthcare. Show all posts

Tuesday, 8 August 2017

Single Cell Analysis Market is expected to reach USD 5.0 billion by 2024

The global Single Cell analysis market is expected to reach USD 5.0 billion by 2024, according to a new report published by Grand View Research, Inc. The rising adoption of Single Cell analysis tools owing to the improving healthcare scenario is fueling the growth of the market.

The continuous efforts in the R&D sector of the healthcare industry are resulting in the wide applicability of the Single Cell analysis technologies in the different disease areas, as a widespread diagnostic tool to address the complex heterogeneity observed in cells. Introduction of stem cell therapies and non-invasive techniques for prenatal analysis are some of the examples of the applications of the Single Cell analysis techniques. On the contrary, the high-cost and long shelf-life of the instruments is challenging the growth of the market.


In addition, the increasing pool of individuals suffering from target diseases, such as cancer, and neurological disorders, rising per capita income, and the government initiatives to encourage the R&D in healthcare sectors are augmenting the demand for Single Cell analysis in the developing countries. The extensive demand for non-invasive techniques for prenatal diagnosis to prevent the immunological and genetic disorders in fetuses is fueling the demand for Single Cell tests in the market. The penetration of advanced therapeutic tools for the treatment of chronic diseases, such as cancer related to the malfunctions of the Single Cells is proving to be a boon for the global market. Moreover, the adoption of stem cell therapy for treatments related to bone marrow transplants, hair regeneration, and other health-related issues is widening the scope of the Single Cell analytical technologies globally.

Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). North America accounted for the largest market share and was followed by Europe in 2015.Well-developed healthcare and R&D infrastructure and the availability of skilled labor are pushing the adoption of Single Cell analysis in these regions.

AsiaPacificis expected to show the fastest growth rate during the forecast period. Factors, such as the booming medical tourism, availability of advanced healthcare treatments, and the availability of skilled healthcare professionals at a lower cost are some of the factors anticipated to accelerate the adoption of Single Cell analysis in the Asia Pacific region. Moreover, the increasing government expenditure for clinical research activities and the improvement of healthcare infrastructure are boosting the growth of the market. As a result, the Asia Pacific market is anticipated to capture around 21% of the global share during the forecast period.

Players are implementing strategies, such as partnerships, collaborations, and mergers to expand their market share. The collaborative agreement between Illumina, Inc. and Bio-Rad Laboratories, Inc. is one such example of the strategic endeavors undertaken by the market players.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • The consumables segment accounted for the largest market share and is expected to maintain its dominance owing to the repeat purchase of reagents, assay kits, beads, and microplates
  • The instruments market segment is expected to show significant growth during the forecast period
  • The applications segment of the market is further divided into cancer, neurology, immunology, prenatal diagnosis, and in-vitro fertilization. Increasing prevalence of the target diseases is propelling the growth of the market. 
  • North America captured the largest market share of around 38% in 2015 and is estimated to maintain its dominance throughout the forecast period. Speedy adoption of analytical techniques and the rising R&D efforts in the field of diagnostics are the major factors contributing to the largest market share of North America in the global market. The AsiaPacific region is expected to show significant growth from 2016 to 2024 due mainly to the flourishing clinical research sector, medical tourism, and the high government healthcare expenditure in the region.
  • The major market players in this market include but are not limited to Thermo Fisher Scientific, Inc., Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Merck Millipore GmbH, Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.)

See More Reports of This Category:

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Surface Marker Detection Market is expected to reach USD 6.49 billion by 2022

The global cell surface marker detection market is expected to reach USD 6.49 billion by 2022, according to a new report by Grand View Research, Inc. This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders. 


Rapid introduction of advancements and automations in clinical laboratories is a key factor affecting this industry. Incorporation of novel algorithms pertaining to diagnosis and prognosis of chronic disorders is expected to fuel demand of this market in the coming years. 

Requirement of solutions for data handling and interpretation of clinical conditions based on obtained results are anticipated to enhance potential for R&D in this sector, consequently driving market growth over the forecast period.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • Flow cytometry devices accounted for over 70% of the revenue generated in the industry for 2014. This large share can be attributed to the growing advancement in these instruments such as enhancement in efficiency and resolution of fluorescence-based cytometric detectors. Furthermore, presence of large product portfolio of different industry players operating in cytometry is responsible for large market share of this technique. 
  • Disease diagnosis and identification accounted for over 50% of the revenue generated in the market for 2014. High incidence rate of cell-associated disorders and oncology diseases that need to be treated in order to curb the mortality rate are the major drivers for growth of this segment. 
  • Determination of novel drug targets and development of biopharmaceuticals for prognosis of chronic diseases is anticipated to propel growth of research and drug discovery sub-segment in the coming years. With expected development of this segment, the sector will witness lucrative growth over the forecast period. 
  • North America accounted for the largest share of this sector for 2014, as there are is significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for biopharmaceuticals is also anticipated to fuel regional growth. 
  • North America dominated the industry in 2014, with revenue estimated at USD 999.0 million. Presence of sophisticated healthcare infrastructure and favorable government initiatives with respect to analytical techniques and their applications for disease diagnosis and drug development are some key factors likely to drive growth. 
  • Asia Pacific is expected to witness lucrative growth from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment and growing medical expenditures in emerging economies of India and China 
  • Key participants of the cell surface marker detection industry include Siemens Healthcare, Nihon Kohden Corporation, Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo Fisher Scientific, BioRad Laboratories Inc., and F. Hoffman La Roche Ltd. 
  • These participants are involved in R&D for production of cell-specific antibodies and collaborations with smaller entities operating in the market as well as with academic research laboratories in order to maintain their market position and enter the untapped market regions

See More Reports of This Category:

About Grand View Research:


Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Patient Portal Market is expected to reach USD 5.2 billion by 2024

The global patient portal market is expected to reach USD 5.2 billion by 2024, according to a new report by Grand View Research, Inc. The demand for Electronic Health Record (EHR) with a patient portal is expected to exhibit an upsurge over the forecast period, owing to the increasing demand, favorable government funding policies, and the continual technological advancements offered by the key industrial players.


In May 2016, CureMD signed a pledge of Voluntary National Interoperability. This pledge stated that action plans to develop and implement rapid flow in healthcare information between providers, patients, and other concerned authorities are to be implemented.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • Integrated Patient portal was identified as the most lucrative segment in 2015. The rapid shift of providers from their previous methods to the EHRs, advancements in technology, and increasing demand were some of the reasons for its largest market share. 
  • In June 2015, ICON (a global drug development and service provider) launched its online “Firecrest Patient Portal” It was specifically designed for a person to understand the entire treatment process before consulting the provider and view information regarding clinical trials. 
  • Moreover, this provided services such as online appointment registration, laboratory tests and reports, and other necessary facilities. 
  • Also, as per a report by the European commission, 11regions across the European Union (EU) had participated in the “Sustains project” since 2012, which was EU sponsored. This project was an initiative for joint learning, providing patients’ access to their health records and other online services. 
  • North America dominated the market in 2015 as a result of the technological advancements and implementation of healthcare IT in the region. 
  • In June 2014, Brattleboro Memorial Hospital launched “myHealthPortal.” It is expected to provide easy and early access to the selected portions of the health records. It is safe and secure, providing confidential communication between the providers and the patient. 
  • Europe is expected to grow at a higher rate over the forecast period due to increasing demand of efficient healthcare delivery and advanced solutions. Increased government initiatives in the region and deployment of EHR-based portal solutions are considered responsible for its high growth rate. 
  • In November 2015, an event was organized in the European Parliament by members of the European Parliament, Health Policy Partnership, Lung Cancer Europe, and European Cancer Patient’s Coalition. This event witnessed the launch of an Immuno-oncology Patient Portal that proved to be a unique solution for people suffering from cancer in Europe. 
  • Developers are collaborating and expanding with the aim of combining the use of innovation and technology to improve efficiency and provide better services for the convenience of the providers. 
  • In 2016, McKesson Corporation announced a partnership with Blue Cross Blue Shield of Arizona. This partnership will help deliver a broad range of services, thereby assisting the service providers. 
  • In 2015, GE Healthcare announced the acquisition of Camden Group in order to provide their clients access to analytics that involves change management and activation resources, which support organizational and clinical changes. 
  • Some key players in this market are GE Healthcare, Allscripts Healthcare Solutions, McKesson Corporation, and Cerner Corporation.

See More Reports of This Category:

About Grand View Research:


Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 7 August 2017

Healthcare Analytics Market is expected to reach USD 42.8 billion by 2024

The global healthcare analytics (HA) market is expected to reach USD 42.8 billion by 2024, according to a new report by Grand View Research, Inc. Efforts to reduce the spiraling healthcare costs is facilitating the usage of the healthcare analytics. Additionally, the benefits of HA include the improvement of patient access to customized care, the furthering of transparent operations to enable better public oversight, and innovation in patient care delivery and services.

Furthermore, analytics play a major part in striving to ameliorate the health economic efficiency. For instance, l’Assurance Maladie in France employed analytics to assess the clinical safety of the class of cholesterol-lowering drugs, statins, which have been implicated in causing severe side-effects, and the derived results were used to introduce evidence-based performance measures to address the cracks in the operational system.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations. On the other hand, predictive analytics is anticipated to grow at a lucrative rate over the forecast period mainly due to its wide applicability in medical systems, such as fraud prevention, disease prevalence forecasts, and risk assessment.
  • The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered. Moreover, the outsourcing of services helps in cutting costs associated with infrastructure requirements and in addition, avoids the requirement of skilled individuals to perform the same task.
  • The hardware systems category dominated the component segment, high-cost of the hardware, such as the use of computer systems and internet servers contributed to its growth.
  • On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015. However, the cloud-based delivery mode segment is anticipated to grow at a profitable rate over the forecast period. The benefits of the cloud system, which include remote data entry and real-time data entry features are expected to result in the growth of this segment.
  • The applications of the healthcare big data include financial applications, operational & administrative applications, and clinical applications. Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.
  • The demand for financial applications is anticipated to boost over the forecast period. These applications include payment and claim settlements and fraud prevention and risk analysis. Various initiatives undertaken by the government, such as the Fraud Prevention System (FPS) from the CMS is promoting its adoption.
  • The end-users of HA include payers, providers, and others. Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate. The usage of these services by providers is for population health management, quality improvement, and personalized care.
  • North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.
  • The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.
  • Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.
  • For instance, in December 2015 Truven Health Analytics, Inc. and Philips Electronics N.V. integrated Truven Health Micromedex Solutions in the management platform, the Tasy System. This integrated platform is anticipated to facilitate fast and easy access to a wealth of evidence-based medical information present in the drug interaction repositories of Micromedex Solutions.

See More Reports of This Category:

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thursday, 3 August 2017

Vein Illuminator Market is expected to reach USD 358.5 million by 2024

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future.


The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly.

On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region.
  • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment.
  • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions.
  • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system.

See More Reports of This Category:

About Grand View Research:


Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wednesday, 2 August 2017

Cord Blood Banking Service Market is expected to reach over USD 12 billion by 2022

The global market for cord blood banking (CBB) service is expected to reach over USD 12 billion by 2022, growing at an estimated CAGR of around 11% from 2015 to 2022, according to a new report by Grand View Research, Inc. Key drivers of the market include increasing application of stem cell therapy in disease treatment, and rising prevalence of life threatening genetic disorders. 


Moreover, increasing spending capacity is fueling the demand for advanced healthcare facilities including prevention and treatment. As a result, parents are increasingly demanding CBB Service to ensure safety of their child’s future. Furthermore, private players are practicing marketing activities which are creating awareness about the availability of the CBB Service and their benefits. 

In addition, governments worldwide are promoting public CBB to develop ethnically diverse cord blood repository which would increase the chances of finding suitable human leukocyte antigen (HLA) match for the patients. As a result, availability of the ethnically rich CB repository coupled with anticipated rise in the stem cell therapies and bone marrow transplants, is expected to spur the CBB Service during the forecast period.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:
  • Private bank segment accounted for the largest market share in 2014. High cost of collection, processing, and storage along with the maximum awareness created by marketing activities practiced by the players resulted in large market share of private banks in the world. 
  • Rising government support and no storage and collection costs are the major factors anticipated to drive the public banking segment during the forecast period from 2015 to 2022 with highest CAGR.  
  • North America dominated the global market and was followed by Europe in 2014. Dominance of North America is accounted by government support and high penetration rate of stem cell therapy in the U.S. and Canada. Moreover, high awareness and insurance coverage of cord blood banking and stem cell therapies is further boosting the growth of the market in North America.
  • Densely populated emerging countries of Asia Pacific are anticipated to show significant growth during the forecast period from 2015 to 2022. Factors such as increasing investment by global players, government support and rising healthcare expenditure are anticipated to boost the cord blood banking Service market in Asia Pacific.
  • Global cord blood banking Service market is highly fragmented with presence of many private and public players. Few global players operate in various geographies through subsidiaries. While local players are operating independently in respective geographies. 
  • Key players of this market include China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Limited, Cryo-Cell International, Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord, Inc. and Virgin Health Bank


See More Reports of This Category:


About Grand View Research:


Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Brain Computer Interface Market is expected to reach USD 1.7 billion by 2022

Global Brain Computer Interface (BCI) Market is expected to reach USD 1.7 billion by 2022, according to a new study by Grand View Research Inc. Increasing incidences of neurodegenerative conditions, advancements in neuroscience, rising geriatric population base and the growing demand for neuroprosthetics are some impact rendering drivers of the brain computer interface market. Furthermore, growing R&D investments and the presence of government projects such as DECODER (European project that used brain computer interface to detect consciousness in non responsive patients) coupled with rising focus of major market players on emerging economies such as Japan and China are also expected to propel market growth over the forecast period. Introduction of technological advancements occurring in the market is expected to result in the availability of better options for healthcare personnel and individuals. The technology encompasses a wide array of applications designed to revolutionize the communication, automation, security and entertainment experience. Brain computer interface is an emerging technology which is currently at a nascent stage; however, the increasing interest among researchers in collaboration with the government is expected to fuel the future growth of this market.


To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • Non-invasive BCI is identified as the most lucrative product sub segment of the market and is expected to grow at a rate of over 10.0% over the forecast period majorly owing to, increasing prevalence of paralysis.
  • BCI based healthcare segment accounted for the largest market share in 2014. Rising incidences of brain related disorders, increasing R&D spending over medical applications and growing base of geriatric population are some driving factors for this segment.
  • North America was the largest regional market with a revenue share of over 40.0% in 2014 on account of the presence of an extensive number of ongoing BCI projects. Growing patient awareness level and accessible healthcare infrastructure is also expected to lead to an expedited market growth over the forecast period.  
  • Asia Pacific is identified as the most lucrative regional market. Large presence of untapped opportunities coupled with rapidly improving economic conditions is expected to drive regional market growth over the forecast period. China is expected to witness the fastest growth over the forecast period.
  • Key players of the brain computer interface market include Emotiv System, Mind Solutions Corp., Puzzlebox, Natus Medical, Interactive Productline, Compumedics Ltd. and Neuroelectrics.


See More Reports of This Category:

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Suction Devices Market is expected to reach USD 1.04 billion by 2024

The global medical suction devices market is expected to reach USD 1.04 billion by 2024, according to a new report by Grand View Research. The global medical suction devices market is expected to grow swiftly owing to the increasing prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary diseases, asthma, and lung cancer. Additionally, the market is growing rapidly due mainly to the increasing adoption of suction pumps in the point-of-care facilities. Moreover, the availability of compact suction devices has fostered the usage of these devices in ambulatory and emergency centers.


The government bodies including Ministry of Health and Family Welfare (MOHFW), Central Drugs Standard Control Organization (CDSCO), and Association of Indian Medical Device Industry (AIMED) provide the medical devices sector with a regulatory structure to promote indigenous production. Such regulations are positively impacting the market. Moreover, the increasing number of collaborations undertaken by companies, such as Drive Medical, Olympus Corporation, Laerdal Medical, with the aim of introducing technologically-advanced and improved devices is further boosting the growth of the market.

However, the lack of reimbursement coverage for the homecare suction devices and the high-cost of the wall-mounted devices are some of the factors impeding the growth of the market.

Some of the key players in this market include Allied Healthcare Products, Inc., Precision Medical, Inc., Drive Medical, INTEGRA Biosciences AG, Medicop, Inc., SSCOR, Inc., ATMOS MedizinTechnik GmbH & Co. KG, ZOLL Medical Corporation, Welch Vacuum, Laerdal Medical, Labconco Corporation, Amsino International Inc., and Olympus Corporation.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • The non-portable segment is anticipated witness lucrative growth during the forecast period owing to the increasing number of surgical procedures and the high price of the devices. As a result, this segment is projected to grow at the highest CAGR from 2016 to 2024.
  • The upsurge in the number of hospitals, clinics, and other healthcare facilities is propelling the demand for non-portable aspiration devices
  • The electrically powered vacuum systems segment captured the largest market share in 2015.The large market share of the segment was attributed to the widespread awareness and adoption of these devices in surgical settings.
  • The portable segment is expected to show rapid growth during the forecast period owing to the rising adoption of home healthcare services where portable and user-friendly medical devices are in demand
  • North America captured the largest market share of around 30% in 2015. Some factors contributing to the dominance of the segment include the presence of well-established healthcare infrastructure, existence of the leading market players, and the easily attainable approval for the class I devices by the U.S. Food and Drug Administration (FDA)
  • Asia Pacific is identified as the fastest growing market for medical suction devices. The factors including a large number of untapped customers, the growing trends in the adoption of the technically-advanced devices, and the expected rise in the target patient population are anticipated to drive the growth of the market.

See More Reports of This Category:

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Liver Diseases Therapeutics Market is expected to boost the growth of industry in future period

The liver diseases therapeutics market had value over USD 7,498.0 million in 2014. The major driving factors are increasing numbers of liver diseases like hepatocellular carcinoma and vast unexploited need of patients with these types of diseases. In addition, increasing geriatric population globally is estimated to augment the market demand in the future period.


Huge expenditure by biotechnology and pharmaceutical industries on R&D and availability of sturdy pipeline are the major expected boosting factors for the growth of liver diseases therapeutics market in future period. Governments’ and big companies’ vaccination program are creating awareness about the illness and prevention is boosting the growth of the market.

The market is bifurcated into products and regions. New products are rapidly being launched boosting the market growth. The growth of the market is boosted by the strategic alliances, joint venture between the major players, and growing awareness of healthcare in the upcoming nations.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:
  • Nonetheless, risks and side effects linked with existing medication & stringent FDA and other norms approved by the government along with accessibility of varying treatment measures perform as barriers to the industry. The market was dominated by the antiviral drug sector with a value over USD 2631 million in revenue terms in 2014.
  • Rising population with liver diseases due to increasing number of alcohol consumers is estimated to boost the market share. Alternatively, the antiviral drug is estimated to observer profitable raise of over 8.8% from 2015 to 2022. This is due to the occurrence of drugs in the pipeline.
  • The market is estimated to be at over USD 12095.0 million by 2022. This is going to happen due to the increasing geriatric population, rising liver ailments like hepatocellular and hepatitis carcinoma along with high requirement for programs on vaccination in developing nations and high spending on growing healthcare in the developed nations.
  • North America is dominating the global market due to academic and research institutions performing studies related to medical trials. North America had more than 39% share of the global market in 2014 and is anticipated to carry on leading till 2022. Asia Pacific had share over USD 1615.5 million in 2014 and is estimated at CAGR over 8.5% in the future.
  • Few of the major industries are Abbott Laboratories, Gilead Sciences, Astellas Pharma Inc., GlaxoSmithKline plc, Bristol-Mayers Squibb, and Merck & Co., Inc.

See More Reports of This Category:

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Tuesday, 1 August 2017

Medical Sensors Market is expected to reach USD 18.5 billion by 2024

The medical sensors market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research, Incite upsurge in the number of patients afflicted with chronic conditions, such as diabetes and hypertension, is fueling the usage of monitoring as well therapeutic devices, thus boosting the market demand. 

The target population for this market is patients with chronic illnesses, as such conditions necessitate regular checkups and intermittent or continuous patient monitoring. The rise in population of chronically ill patients further increases the uptake of the medical sensors. 


The geriatric population is highly prone to developing chronic disorders and they pose a higher risk of developing age-related deformities and complications. Moreover, the adoption of unhealthy food habits and sedentary lifestyles and the resultant surge in the incidence of obesity has led to the increasing prevalence of lifestyle disorders including diabetes. The presence of a large target population base combined with the prevalence of lifestyle-related risk factors is likely to accelerate the growth of the medical sensors market during the forecast period. 

Technological advancements in terms of accuracy, portability, and affordability associated with the new generation medical sensors resulted in the increased usage of these devices; for instance, the introduction of easy-to-operate, home-based diagnostic kits that are cost effective.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • The biosensors products segment held a lucrative share of over 40.0% in 2015. This is ascribable to the following attributes of the novel biosensors: durability, reliability, and accuracy. Moreover, their applications in the healthcare areas, such as the detection of drug abuse, glucose monitoring for diabetes, the detection of cholesterol, and others. All these elements governed the growth of this segment in 2015. 
  • The surgical applications of the sensors dominated the market in 2015. Whereas, the monitoring applications segment is projected to be the fastest growing during the forecast period. Advancements, such as wearable technology are anticipated to boost the demand for the monitoring devices market. 
  • The hospitals registered a remunerative growth in 2015; this can be attributed to the presence of a well-developed healthcare infrastructure, which yields faster and accurate diagnosis. Moreover, the availability of well-equipped infrastructure coupled with the presence of skilled personnel and technologically advanced equipments contribute towards the lucrative growth of this segment. 
  • North America held a considerably large share of over 35.0% in 2015 owing to the presence of leading sensor manufacturers, a well-planned medical reimbursement network, and the increasing disposable income 
  • On the contrary, Asia Pacific is anticipated to be the fastest growing region with a CAGR of over8.0% over the forecast period. The favorable economic developments and the advancing healthcare system with the aid of supportive government initiatives are anticipated to further assist the growth. Moreover, the increasing base of the aging population in this region also, additionally impels the demand. According to the report published by the Ministry of Statistics, in India, 8.6% of the total population is aged above 60; hence, presenting a profitable opportunity for the market players to invest in this region. 
  • The leading players of the medical sensors market include Analog devices, Inc., Avago technologies Ltd., Danaher Corporation, GE Measurement &Control Solutions, Inc., Honeywell International, Inc., Stellar technologies, Inc., OmniVision Technologies, Inc., Sensation AG, TE Connectivity Ltd., Micro-Epsilon Messtechnik GmbH Co. & KG, and NXP Semiconductors N.V.

See More Reports of This Category:

About Grand View Research:


Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ingestible Sensors Market is expected to reach USD 2.0 billion by 2024

Ingestible sensors market is expected to reach USD 2.0 billion by 2024, according to a new report by Grand View Research, Inc. The escalation in the geriatric population has driven the demand for improved, minimally-invasive, medical technologies and devices to address the needs of the elderly population subset. With the advent of the sensors that can be ingested, the internal anatomy of the human body can be easily studied and monitored with changes in pressure, temperature, and pH recorded constantly.

The internal anatomy can also be captured with the help of an image sensor, enabling enhanced visualization of the gastrointestinal tract along with any anomalies that maybe causing digestive perturbations; thus, expediting conclusive disease diagnosis with greater clarity while obviating cumbersome procedures, such as endoscopy.


The growing number of chronic diseases like cardiac diseases, obesity and diabetes along with cancer require constant physiological monitoring of vital bodily functions, which is easily met by the use of ingestible sensors. Favorable reimbursement options provided by governments and insurance companies have promoted the adoption of these devices to a larger extent. Compliance with medication regimes has increased significantly in patients, which has further encouraged the adoption of these ingestibles.

The major restraints in the ingestible sensors market are technical and clinical constraints along with the substantially large technological costs associated with manufacturing and designing of these sensors that require high capital funds.

On the basis of components, the ingestible sensors market is segmented into sensors, wearable data recorder, and software. The sensor components enable data collection and wireless transmission of the recorded data for it to be decoded by the software into clinically meaningful data for further analysis to be performed.

The various kinds of sensors available are temperature, pressure, pH, and image sensors. The medical applications of the sensors are wide ranging as they support wireless and remote, patient monitoring as well as diagnostic imaging. All sensor devices are equipped with technical components that facilitate physician access to the diagnostic output on easily operable user interfaces. 

The medical vertical has been the highest gaining segment owing to the use of ingestible sensors in clinics and hospitals. These sensors furnish medical professionals with accurate, real-time data for multiple parameters through non-invasive and wireless technology; in consequence, these devices are a mainstay of diagnostic procedures. In other segments including sports and fitness, the wearable sensors that monitor vital signs to check serious ailments, have gained significant momentum.

To request a sample copy or view summary of this report, click the link below:


Further key findings from the study suggest:

  • The major market share is estimated to be dominated by the North America region due largely to the technological advancements and the pre-existing robust research and development base. The majority of the companies dominating the market has progressed in terms of designing and manufacturing of sensors and is at present focusing on refining the existent products.
  • The Asia Pacific region is set to grow at a steady pace due to the increasing adoption of ingestible sensors in hospitals and clinics. With a huge target population base in this region including the escalating geriatric patient count afflicted with chronic diseases, smart pill technology, such as ingestibles address the need for novel technology to incorporate minimally invasive procedures in the diagnostic process.
  • Temperature and image sensors are the major profit gainers among the ingestible sensors as they furnish accurate readings with respect to the body temperature and metabolic changes; hence, facilitating easy interpretation
  • The medical vertical is expected to be the highest gaining segment owing to the increasing adoption of ingestible sensors in patients, followed by the sports and fitness segments
  • Some key market players include Proteus Digital Health, Inc., CapsoVision, Inc., Given Imaging, Inc., and Olympus Corporation, among others

See More Reports of This Category:

About Grand View Research:


Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.